BBHC CO LTD has a total of 50 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are HALO BIO RNAI THERAPEUTICS INC, NAKAYAMA TOMOKO and STEM CELL & REGENERATIVE MEDICINE INTERNATIONAL INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | China | 7 | |
#4 | EPO (European Patent Office) | 7 | |
#5 | Australia | 6 | |
#6 | Hungary | 5 | |
#7 | Serbia | 5 | |
#8 | Canada | 1 | |
#9 | Mexico | 1 | |
#10 | Philippines | 1 | |
#11 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Lee Sang Yeon | 44 |
#2 | Kim Ho Bin | 44 |
#3 | Lee Kye Ho | 44 |
#4 | Oh Min Sun | 44 |
#5 | Jung Won Ju | 44 |
#6 | Lee Sang-Yeon | 4 |
#7 | Lee Kye-Ho | 3 |
#8 | Jung Won-Ju | 3 |
#9 | Kim Ho-Bin | 3 |
#10 | Oh Min-Sun | 3 |
Publication | Filing date | Title |
---|---|---|
EP3064572A1 | Method for producing induced pluripotent stem cell from mesenchymal stem cell and induced pluripotent stem cell produced by the method |